PATENT CLAIM ANALYSIS

Application Number: 16011018
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "217060"]

Abstract:
Compounds of the formula I or II: wherein X, m, Ar, R 1  and R 2  are as defined herein. The subject compounds are useful for treatment of IRAK-mediated conditions.

Claim (Index 9):
The compound of  claim 1 , wherein Ar is optionally substituted heteroaryl.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 94.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14243074', '10225783', '13546039', '15850720', '14511847']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8024017460721049
- 35 USC 102 Novelty (BERT): 0.5601914635282386
- Combined Prediction Score: 0.7781807178177184
- Mean Citation Score: 340.745314
- Max Citation Score: 462.62836
- Similarity Product: 322.3359720938612

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test